Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead. Thank you. Joining me on the call today is TJ Schaefer, Arcadia's President and Chief Executive Officer. This call is being webcast, and you can refer to the company's press release at arcadiabio.com. Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, The company's actual performance and results may differ materially from those described or implied today. You can review the company's safe harbor language and our most recently filed 10-K. With that, I'll now turn the call over to TJ. Thanks, Mark, and thank you to everyone on the call for joining us today to discuss our 2025 first quarter financial results. It has only been seven weeks since we delivered our 2024 year-end update. but the momentum from the second half of 2024 has carried into 2025, and I am very pleased with our first quarter results. Zola Coconut Water continues to thrive and outperform our own internal expectations. In Q1 2025, our reported Zola sales increased 90% year over year, primarily driven by new distribution gains, which increased 70% compared to ...